HIV Vaccine Candidate Induces Immune Response In Phase I Clinical Trial

December 02, 2022

CNN (12/1, Howard) reports, “An experimental HIV vaccine has been found to induce broadly neutralizing antibodies among a small group of volunteers in a Phase 1 study.” The clinical trial results “suggest that a two-dose regimen of the vaccine given eight...